Panelists discuss how they approach long-term monitoring and follow-up care for ALK+ patients to maintain optimal outcomes on ...

Panelists discuss how practice improvements and patient resources can be implemented to empower both healthcare providers and ...

Panelists discuss how patient-specific factors, including brain metastases and drug tolerability, influence front-line ALK ...

Panelists discuss how they manage adverse events associated with ALK inhibitors, comparing safety profiles and addressing ...

Panelists discuss how they support patients through disease progression and treatment transitions by educating on resistance ...

Panelists discuss how patient education strategies support long-term treatment success, adherence, and shared decision-making ...

Panelists discuss how they monitor and educate patients on ALK inhibitor side effects while equipping nursing staff to manage ...

Panelists discuss how strategic nursing coordination and effective communication support timely and comprehensive biomarker ...

Panelists discuss how evolving clinical advances and biomarker-driven therapies have transformed treatment practices and ...

Panelists discuss how they prepare patients for ALK inhibitor therapy following a confirmed ALK-positive result.

A care model led by advanced practice nurses was feasible in providing supportive care and linking providers through ...

Maria C. Velez, MD, shared that teamwork between pediatric and adult care teams can make the transition of care smoother for ...